PT343 – Soren Shade – Kratom and Anti-Prohibition: Lessons Learned and...

COMPASS Pathways to participate in upcoming BTIG Biotechnology Conference and Canaccord...

Braxia Scientific Reports Fourth Quarter and FY 2022 Financial Results

atai Life Sciences to Announce Second Quarter 2022 Financial Results and...

BREAKING: Morgan Stanley Publishes Optimistic Report on Psychedelics

Algernon Pharmaceuticals Reports Additional Positive Data From its Phase 2 Study...

FILAMENT HEALTH ANNOUNCES PARTICIPATION IN PROJECT SOLACE

PT342 – Spencer Hawkswell – The Right to Psilocybin in Canada:...

Psychedelic Bulletin #112 – Inside the DEA Challenge; Second Psychedelics Company...

Inside the Challenge to DEA’s Proposed Scheduling of 5 Psychedelic Tryptamines

Load more